Convatec Group (LON:CTEC) Reaches New 12-Month High – Time to Buy?

Shares of Convatec Group PLC (LON:CTEC – Get Free Report) reached a new 52-week high during trading on Monday. The stock traded as high as GBX 259.80 and last traded at GBX 258, with a volume of 8,874,752 shares. The stock had previously closed at GBX 257.40.

Analysts Set New Price Targets

CTEC has been the topic of several research reports. Royal Bank Of Canada reissued an “outperform” rating and set a GBX 315 price target on shares of Convatec Group in a research note on Monday, August 3rd. Berenberg Bank cut their price objective on shares of Convatec Group from GBX 340 to GBX 335 and set a “buy” rating for the company in a research note on Friday, September 11th. Jefferies Financial Group reiterated a “buy” rating and issued a GBX 300 price objective on shares of Convatec Group in a report on Wednesday, August 5th. Peel Hunt reiterated an “add” rating and set a GBX 270 price target on shares of Convatec Group in a report on Tuesday, August 4th. Finally, Deutsche Bank reissued a “buy” rating and set a GBX 315 target price on shares of Convatec Group in a research note on Wednesday, August 5th. Eight equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Convatec Group currently has an average rating of “Moderate Buy” and an average price target of GBX 305.44.

View Our Latest Report on Convatec Group

Convatec Group Stock Up 0.2%

The company has a quick ratio of 0.96, a current ratio of 1.93 and a debt-to-equity ratio of 121.83. The company has a market cap of £4.93 billion, a PE ratio of 41.61, a PEG ratio of 0.93 and a beta of 0.77. The company’s fifty day moving average is GBX 230.34 and its 200-day moving average is GBX 224.01.

Insider Activity

In other news, insider Jens Viebke bought 24,400 shares of the stock in a transaction that occurred on Tuesday, October 13th. The shares were bought at an average price of GBX 230 per share, for a total transaction of £56,120. 1.00% of the stock is currently owned by company insiders.

About Convatec Group

(Get Free Report)

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.

Further Reading

Receive News & Ratings for Convatec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Convatec Group and related companies with MarketBeat.com's FREE daily email newsletter.